
New drugs could get “near automatic” sign off for use in the UK under plans to enter new partnerships with other international drugs regulators.
Chancellor Jeremy Hunt announced that £10 million is to be given to the UK regulator – the Medicines and Healthcare products Regulatory Agency (MHRA) – to help streamline approvals for new medical products.